GABRIEL LEUNG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GABRIEL LEUNG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GABRIEL LEUNG. GABRIEL LEUNG is a Exec. VP, Pres., Oncology Bus. in OSI PHARMACEUTICALS INC ($OSIP) and a Exec. VP,/Pres., Oncology Bus. in OSI PHARMACEUTICALS INC ($OSIP) and a Director in PERNIX THERAPEUTICS HOLDINGS, INC. ($GTA) and a Director in ALBANY MOLECULAR RESEARCH INC ($AMRI) and a Director in Novocure Ltd ($NVCR).
Address: C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE 11747 NY
Companies in which GABRIEL LEUNG is an Insider
ALBANY MOLECULAR RESEARCH INC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of GABRIEL LEUNG: Director
Holdings: 31,316 shares
Current Value: $577,467
Latest Transaction: Mar 04 2015
$AMRI Market Capitalization: $765.67M
$AMRI Previous Close: $18.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NovoCure Ltd
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of GABRIEL LEUNG: Director
Holdings: 78,045 shares
Current Value: $530,706
Latest Transaction: Apr 15 2021
$NVCR Market Capitalization: $581.43M
$NVCR Previous Close: $6.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OSI PHARMACEUTICALS INC
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of GABRIEL LEUNG: Exec. VP, Pres., Oncology Bus., Exec. VP,/Pres., Oncology Bus.
Holdings: 10,429 shares
Latest Transaction: Jun 17 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PERNIX THERAPEUTICS HOLDINGS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GABRIEL LEUNG: Director
Holdings: 0 shares
Latest Transaction: May 23 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GABRIEL LEUNG
Sentiment: All, AMRI, NVCR, OSIP, GTA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 2021 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 31.45 | 6,000 | 188,700 | 6,345 | |
| Apr 15 2021 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 200.00 | 2,500 | 500,000 | 72,045 | 74.5 K to 72 K (-3.35 %) |
| Apr 15 2021 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 198.01 | 3,500 | 693,035 | 74,545 | 78 K to 74.5 K (-4.48 %) |
| Apr 15 2021 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 31.45 | 6,000 | 188,700 | 78,045 | 72 K to 78 K (+8.33 %) |
| Sep 16 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.48 | 7,392 | 55,292 | 0 | |
| Sep 16 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.48 | 2,173 | 16,254 | 0 | |
| Sep 16 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.48 | 10,000 | 74,800 | 2,173 |